Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 182

The DOI matches its Crossref record.

A multicentric, placebo‐controlled, double‐blind clinical trial of β‐sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia

KLIPPEL, K.F., HILTL, D.M., SCHIPP, B., for the German BPH‐Phyto study group‡ · 1997 · British Journal of Urology

Abstract

Objective: To report the results of a double‐blind, placebo‐controlled trial to evaluate Azuprostat ® , a β‐sitosterol, in patients with symptoms of outlet obstruction caused by benign prostatic hyperplasia (BPH). Patients and methods: A randomized, double‐blind and placebo‐controlled clinical trial was conducted to assess the efficacy and safety of 130 mg free β‐sitosterol (phytosterol) daily, using the international prostate symptom score (IPSS) as the primary outcome variable. In total, 177 patients with BPH were recruited for 6 months of treatment in 13 study centres. In addition to the relative difference in the IPSS, changes in quality of life, peak urinary flow rate (Q max ) and post‐void residual urinary volume (PVR) were recorded. The drug used in the trial consisted of a chemically defined extract of phytosterols, derived for example from species of Pinus , Picea or Hypoxis , with β‐sitosterol as the main component. Results: There were significant ( P <0.01) improvements over placebo in those treated with β‐sitosterol; the mean difference in the IPSS between placebo and β‐sitosterol, adjusted for the initial values, was 5.4 and in the quality‐of‐life index was 0.9. There were also significant improvements in the secondary outcome variables, with an increase in Q max (4.5 mL/s) and decrease in PVR (33.5 mL) in favour of β‐sitosterol when adjusted for the changes after placebo. Conclusion: These results show that β‐sitosterol is an effective option in the treatment of BPH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-410x.1997.t01-1-00362.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 182

Metadata

Authors
KLIPPEL, K. F., HILTL, D. M., SCHIPP, B., & for the German BPH‐Phyto study group‡
Venue
British Journal of Urology
Publisher
Wiley
Published
1997-09
Volume
80
Issue
3
Pages
427-432
ISSN
0007-1331 (ISSN-L)
OpenAlex
W2076498366
Cited by
182
References
0
FWCI
10.75
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A multicentric, placebo‐controlled, double‐blind clinical trial of β‐sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. https://app.cochat.ai/papers/10.1046/j.1464-410x.1997.t01-1-00362.x
The paper
KLIPPEL, K. F., HILTL, D. M., SCHIPP, B., & for the German BPH‐Phyto study group‡. (1997). A multicentric, placebo‐controlled, double‐blind clinical trial of β‐sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. British Journal of Urology. https://doi.org/10.1046/j.1464-410x.1997.t01-1-00362.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.